UK markets open in 4 hours 5 minutes
NIKKEI 225
37,780.35 +151.87 (+0.40%) HANG SENG
17,561.86 +277.32 (+1.60%) CRUDE OIL
83.80 +0.23 (+0.28%) GOLD FUTURES
2,344.50 +2.00 (+0.09%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,597.52 +208.97 (+0.41%)
Sage Therapeutics, Inc. (SAGE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 817.27M |
| Enterprise value | 103.56M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.94 |
| Price/book (mrq) | 1.16 |
| Enterprise value/revenue | 1.20 |
| Enterprise value/EBITDA | -0.19 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.85 |
| 52-week change 3 | -72.20% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 59.99 |
| 52-week low 3 | 10.92 |
| 50-day moving average 3 | 18.93 |
| 200-day moving average 3 | 22.41 |
Share statistics
| Avg vol (3-month) 3 | 1.04M |
| Avg vol (10-day) 3 | 1.71M |
| Shares outstanding 5 | 60.11M |
| Implied shares outstanding 6 | 60.11M |
| Float 8 | 47.55M |
| % held by insiders 1 | 12.56% |
| % held by institutions 1 | 95.82% |
| Shares short (15 Apr 2024) 4 | 9.31M |
| Short ratio (15 Apr 2024) 4 | 11.22 |
| Short % of float (15 Apr 2024) 4 | 23.37% |
| Short % of shares outstanding (15 Apr 2024) 4 | 15.49% |
| Shares short (prior month 15 Mar 2024) 4 | 8.4M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -54.23% |
Management effectiveness
| Return on assets (ttm) | -30.51% |
| Return on equity (ttm) | -52.77% |
Income statement
| Revenue (ttm) | 86.45M |
| Revenue per share (ttm) | 1.45 |
| Quarterly revenue growth (yoy) | 2,621.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -545.07M |
| Net income avi to common (ttm) | -541.49M |
| Diluted EPS (ttm) | -9.05 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 753.18M |
| Total cash per share (mrq) | 12.53 |
| Total debt (mrq) | 5.17M |
| Total debt/equity (mrq) | 0.65% |
| Current ratio (mrq) | 10.51 |
| Book value per share (mrq) | 13.32 |
Cash flow statement
| Operating cash flow (ttm) | -540.59M |
| Levered free cash flow (ttm) | -333.05M |
© 2024 Yahoo. All rights reserved.